Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40ANB | ISIN: US03815U4094 | Ticker-Symbol: UDJ
München
21.01.25
08:00 Uhr
0,208 Euro
0,000
0,00 %
1-Jahres-Chart
APPLIED DNA SCIENCES INC Chart 1 Jahr
5-Tage-Chart
APPLIED DNA SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,2001,25021.01.

Aktuelle News zur APPLIED DNA SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.01.APPLIED DNA SCIENCES INC - 8-K, Current Report-
10.01.APPLIED DNA SCIENCES INC - S-1/A, General form for registration of securities1
10.01.Applied DNA Sciences, Inc.: Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates571- Signals Start of New Commercialization Phase for LineaRx Subsidiary -- Company Negotiating GMP Supply Agreement -- Company Reaffirms Strategic Restructuring Timeline - STONY BROOK, NY / ACCESSWIRE...
► Artikel lesen
08.01.Applied DNA Sciences, Inc.: Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter284STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced...
► Artikel lesen
APPLIED DNA SCIENCES Aktie jetzt für 0€ handeln
18.12.24Applied DNA Sciences, Inc.: Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA259- Regulatory Approval Showcases Clinical Advancement of Linea DNA as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, NY / ACCESSWIRE / December 18, 2024 / Applied DNA Sciences...
► Artikel lesen
17.12.24Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M4
17.12.24Applied DNA Sciences: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines397- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed by January 9, 2025 -- Webcast and Conference Call...
► Artikel lesen
17.12.24APPLIED DNA SCIENCES INC - 10-K, Annual Report1
17.12.24APPLIED DNA SCIENCES INC - 8-K, Current Report-
16.12.24Applied DNA Sciences, Inc.: Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Bu270STONY BROOK, NY / ACCESSWIRE / December 16, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced...
► Artikel lesen
13.12.24APDN-Aktie stürzt auf 52-Wochen-Tief von 0,14 US-Dollar6
13.12.24APDN stock plunges to 52-week low of $0.14 amid steep decline4
02.12.24APDN stock plunges to 52-week low of $0.15 amid market challenges1
02.12.24APDN-Aktie fällt auf 52-Wochen-Tief von 0,15 US-Dollar3
19.11.24APPLIED DNA SCIENCES INC - S-1, General form for registration of securities9
14.11.24APDN-Aktie stürzt auf 52-Wochen-Tief und erreicht 0,17 US-Dollar10
14.11.24APDN stock plunges to 52-week low, touches $0.172
07.11.24APPLIED DNA SCIENCES INC - 8-K, Current Report1
30.10.24Applied DNA Sciences: Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement393STONY BROOK, NY / ACCESSWIRE / October 30, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a...
► Artikel lesen
30.10.24Applied DNA kündigt Wertpapierangebot in Höhe von 6,5 Millionen US-Dollar an13
Seite:  Weiter >>
75 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,5